Abstract:Hydroxycarboxylic acid receptor 2 (HCAR2) belongs to the family of class A G protein-coupled receptors with key roles in regulating lipolysis and free fatty acid formation in humans. It is deeply involved in many pathophysiological processes and serves as an attractive target for the treatment of cardiovascular, neoplastic, autoimmune, neurodegenerative, inflammatory, and metabolic diseases. Here, we report four cryo-EM structures of human HCAR2–Gi1 complexes with or without agonists, including the drugs niacin (2.69 Å) and acipimox (3.23 Å), the highly subtype-specific agonist MK-6892 (3.25 Å), and apo form (3.28 Å). Combined with molecular dynamics simulation and functional analysis, we have revealed the recognition mechanism of HCAR2 for different agonists and summarized the general pharmacophore features of HCAR2 agonists, which are based on three key residues R111 3.36 , S179 45.52 , and Y284 7.43 . Notably, the MK-6892–HCAR2 structure shows an extended binding pocket relative to other agonist-bound HCAR2 complexes. In addition, the key residues that determine the ligand selectivity between the HCAR2 and HCAR3 are also illuminated. Our findings provide structural insights into the ligand recognition, selectivity, activation, and G protein coupling mechanism of HCAR2, which shed light on the design of new HCAR2-targeting drugs for greater efficacy, higher selectivity, and fewer or no side effects.

Structural basis for ligand recognition of the human hydroxycarboxylic acid receptor HCAR3

Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2

Orthosteric and Allosteric Modulation of Human HCAR2 Signaling Complex

Molecular recognition of niacin and lipid-lowering drugs by the human hydroxycarboxylic acid receptor 2

Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2

Structural insights into the human niacin receptor HCA2-Gi signalling complex

Ligand Recognition and Activation Mechanism of the Alicarboxylic Acid Receptors

Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8

Structural Basis for Recognition of Antihistamine Drug by Human Histamine Receptor

Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84

Structural basis of ligand recognition and activation of the histamine receptor family

Structural basis of ligand recognition and design of antihistamines targeting histamine H4 receptor

Cryo-EM structures of adenosine receptor A3AR bound to selective agonists

Structures of the human dopamine D3 receptor-Gi complexes

Cryo-EM structure and biochemical analysis of human chemokine receptor CCR8

Structure-guided engineering of biased-agonism in the human niacin receptor via single amino acid substitution

Molecular Insights into Ligand Recognition and Activation of Chemokine Receptors CCR2 and CCR3

Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling

Structural basis of bile acid receptor activation and Gs coupling

A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55.

Cryo-EM Structure and Biochemical Analysis of the Human Chemokine Receptor CCR8